- Home
- UUU vs IOBT Comparison
UUU vs IOBT Comparison
Compare UUU & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$6.09
HOLD
Current Price
$0.04
Company Overview
Basic Information| Metric | UUU | IOBT |
|---|---|---|
| Founded | 1969 | 2014 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Electronic Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.5M | 12.7M |
| IPO Year | 2025 | 2021 |
Fundamental Metrics
Financial Performance| Metric | UUU | IOBT |
|---|---|---|
| Price | $6.09 | $0.04 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $2.25 |
| AVG Volume (30 Days) | 21.6K | ★ 186.6M |
| Earning Date | 02-19-2026 | 05-13-2026 |
| Dividend Yield | ★ 16.75% | N/A |
| EPS Growth | ★ 229.41 | 26.77 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $23,563,554.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 18.39 | N/A |
| 52 Week Low | $2.09 | $0.03 |
| 52 Week High | $8.27 | $2.79 |
Technical Indicators
Market Signals| Indicator | UUU | IOBT |
|---|---|---|
| Relative Strength Index (RSI) | 55.72 | 25.94 |
| Support Level | $5.54 | N/A |
| Resistance Level | $6.43 | $0.22 |
| Average True Range (ATR) | 0.22 | 0.02 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 85.71 | 15.92 |
Price Performance
Historical Comparison UUU
IOBT
About UUU Universal Security Instruments Inc.
Universal Safety Products Inc is a U.S.-based importer and distributor of home safety devices such as ventilation fans and ground fault circuit interrupters.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.